Philip Day to Female
This is a "connection" page, showing publications Philip Day has written about Female.
Connection Strength
0.114
-
Day P, Secrest S, Davis D, Salas J, van den Berk-Clark C, Kale N, Hearing C, Schneider FD, Scherrer JF. Prescription opioid use duration and beliefs about pain and pain medication in primary care patients. J Opioid Manag. 2020 Nov-Dec; 16(6):425-434.
Score: 0.040
-
Mir TH, Osayande A, Kone K, Bridges K, Day P. Assessing the Quality of the After-Visit Summary (AVS) in a Primary-Care Clinic. J Am Board Fam Med. 2019 Jan-Feb; 32(1):65-68.
Score: 0.035
-
Strenth CR, Pagels P, SoRelle JA, Gonzalez L, Day PG, Gimpel NE, Levy Kamugisha EI, Moore RM, Arnold EM. Predictors of mood or anxiety problems among transgender individuals seeking hormone therapy. Fam Pract. 2023 03 28; 40(2):273-281.
Score: 0.012
-
Allen AN, Jiao R, Day P, Pagels P, Gimpel N, SoRelle JA. Dynamic Impact of Hormone Therapy on Laboratory Values in Transgender Patients over Time. J Appl Lab Med. 2021 01 12; 6(1):27-40.
Score: 0.010
-
SoRelle JA, Jiao R, Gao E, Veazey J, Frame I, Quinn AM, Day P, Pagels P, Gimpel N, Patel K. Impact of Hormone Therapy on Laboratory Values in Transgender Patients. Clin Chem. 2019 01; 65(1):170-179.
Score: 0.009
-
Shakil A, Day PG, Chu J, Woods SB, Bridges K. PedHITSS: A Screening Tool to Detect Childhood Abuse in Clinical Settings. Fam Med. 2018 11; 50(10):763-769.
Score: 0.009